Evaluation of reduced susceptibility to quaternary ammonium compounds and bisbiguanides in clinical isolates and laboratory-generated mutants of Staphylococcus aureus

L. Furi; M.L. Ciusa; Dan Knight; V. Di Lorenzo; N. Tocci; D. Cirasola; L. Aragones; J.R. Coelho; A.T. Freitas; E. Marchi; L. Moce; P. Visa; J.B. Northwood; C. Viti; E. Borghi; G. Orefici; J.L. Martinez; L. Baldassarri; U. Yetis; H.J. Roedger; T. Coque; A. Kalkancy; D. Mora; S. Leib; I. Morrissey; M.R. Oggioni

doi:10.1128/AAC.00498-13

Evaluation of reduced susceptibility to quaternary ammonium compounds and bisbiguanides in clinical isolates and laboratory-generated mutants of Staphylococcus aureus

L. Furi, M.L. Ciusa, Dan Knight, V. Di Lorenzo, N. Tocci, D. Cirasola, L. Aragones, J.R. Coelho, A.T. Freitas, E. Marchi, L. Moce, P. Visa, J.B. Northwood, C. Viti, E. Borghi, G. Orefici, J.L. Martinez, L. Baldassarri, U. Yetis, H.J. RoedgerT. Coque, A. Kalkancy, D. Mora, S. Leib, I. Morrissey, M.R. Oggioni

Marshall Centre

Research output: Contribution to journal › Article › peer-review

89 Citations (Scopus)

Original language	English
Pages (from-to)	3488-3497
Journal	Antimicrobial Agents and Chemotherapy
Volume	57
Issue number	8
DOIs	https://doi.org/10.1128/AAC.00498-13
Publication status	Published - 2013

Access to Document

10.1128/AAC.00498-13

Cite this

Furi, L., Ciusa, M. L., Knight, D., Di Lorenzo, V., Tocci, N., Cirasola, D., Aragones, L., Coelho, J. R., Freitas, A. T., Marchi, E., Moce, L., Visa, P., Northwood, J. B., Viti, C., Borghi, E., Orefici, G., Martinez, J. L., Baldassarri, L., Yetis, U., ... Oggioni, M. R. (2013). Evaluation of reduced susceptibility to quaternary ammonium compounds and bisbiguanides in clinical isolates and laboratory-generated mutants of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy, 57(8), 3488-3497. https://doi.org/10.1128/AAC.00498-13

@article{5602700a67154495b733b77a2ef69eb8,

title = "Evaluation of reduced susceptibility to quaternary ammonium compounds and bisbiguanides in clinical isolates and laboratory-generated mutants of Staphylococcus aureus",

author = "L. Furi and M.L. Ciusa and Dan Knight and {Di Lorenzo}, V. and N. Tocci and D. Cirasola and L. Aragones and J.R. Coelho and A.T. Freitas and E. Marchi and L. Moce and P. Visa and J.B. Northwood and C. Viti and E. Borghi and G. Orefici and J.L. Martinez and L. Baldassarri and U. Yetis and H.J. Roedger and T. Coque and A. Kalkancy and D. Mora and S. Leib and I. Morrissey and M.R. Oggioni",

year = "2013",

doi = "10.1128/AAC.00498-13",

language = "English",

volume = "57",

pages = "3488--3497",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "8",

}

Furi, L, Ciusa, ML, Knight, D, Di Lorenzo, V, Tocci, N, Cirasola, D, Aragones, L, Coelho, JR, Freitas, AT, Marchi, E, Moce, L, Visa, P, Northwood, JB, Viti, C, Borghi, E, Orefici, G, Martinez, JL, Baldassarri, L, Yetis, U, Roedger, HJ, Coque, T, Kalkancy, A, Mora, D, Leib, S, Morrissey, I & Oggioni, MR 2013, 'Evaluation of reduced susceptibility to quaternary ammonium compounds and bisbiguanides in clinical isolates and laboratory-generated mutants of Staphylococcus aureus', Antimicrobial Agents and Chemotherapy, vol. 57, no. 8, pp. 3488-3497. https://doi.org/10.1128/AAC.00498-13

TY - JOUR

T1 - Evaluation of reduced susceptibility to quaternary ammonium compounds and bisbiguanides in clinical isolates and laboratory-generated mutants of Staphylococcus aureus

AU - Furi, L.

AU - Ciusa, M.L.

AU - Knight, Dan

AU - Di Lorenzo, V.

AU - Tocci, N.

AU - Cirasola, D.

AU - Aragones, L.

AU - Coelho, J.R.

AU - Freitas, A.T.

AU - Marchi, E.

AU - Moce, L.

AU - Visa, P.

AU - Northwood, J.B.

AU - Viti, C.

AU - Borghi, E.

AU - Orefici, G.

AU - Martinez, J.L.

AU - Baldassarri, L.

AU - Yetis, U.

AU - Roedger, H.J.

AU - Coque, T.

AU - Kalkancy, A.

AU - Mora, D.

AU - Leib, S.

AU - Morrissey, I.

AU - Oggioni, M.R.

PY - 2013

Y1 - 2013

U2 - 10.1128/AAC.00498-13

DO - 10.1128/AAC.00498-13

M3 - Article

C2 - 23669380

VL - 57

SP - 3488

EP - 3497

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 8

ER -